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Abstract
There were 75 articles published in the Journal of Cardiovascular Magnetic Resonance (JCMR) in 2010, which is a
34% increase in the number of articles since 2009. The quality of the submissions continues to increase, and the
editors were delighted with the recent announcement of the JCMR Impact Factor of 4.33 which showed a 90%
increase since last year. Our acceptance rate is approximately 30%, but has been falling as the number of articles
being submitted has been increasing. In accordance with Open-Access publishing, the JCMR articles go on-line as
they are accepted with no collating of the articles into sections or special thematic issues. Last year for the first
time, the Editors summarized the papers for the readership into broad areas of interest or theme, which we felt
would be useful to practitioners of cardiovascular magnetic resonance (CMR) so that you could review areas of
interest from the previous year in a single article in relation to each other and other recent JCMR articles [1]. This
experiment proved very popular with a very high rate of downloading, and therefore we intend to continue this
review annually. The papers are presented in themes and comparison is drawn with previously published JCMR
papers to identify the continuity of thought and publication in the journal. We hope that you find the open-access
system increases wider reading and citation of your papers, and that you will continue to send your quality
manuscripts to JCMR for publication.
Ventricular volumes function and mass
The definition of normal values for CMR is reasonably
mature, although values for special groups are still being
defined, [2] but a number of research papers are still being
published for assessment of less common parameters of
cardiac performance as well as analysis software.
Reference left atrial dimensions and volumes by steady
state free precession cardiovascular magnetic resonance
Maceira et al published a comprehensive analysis of nor-
mal values for left atrial dimensions and volumes using
steady state free precession cine imaging which is cate-
gorized by age decile, gender and body surface area [3].
This follows detailed description of normal values for the
left ventricle (LV), [4] and right ventricle (RV) [5]. These
data are important for clinical and research purposes as
they not only provide normal values for the most com-
monly used cine imaging technique in current CMR use,
but also they show the importance of adjusting for
important covariables, which affects the categorisation
into normal and abnormal. For the left atrium, the body
surface area has a particularly significant effect on normal
values. These values are also important for research.
Relation between cardiac dimensions and peak oxygen
uptake
Steding et al describe a study of 113 subjects of whom 71
were athletes of both genders, to test the hypothesis that
total heart volume is an independent predictor of peak
oxygen uptake, which is known to increase with long
term endurance training and relate to left ventricular
mass [6]. Multivariable analysis showed that total heart
volume was a strong, independent predictor of peak
oxygen uptake (R
2 = 0.74, p < 0.001), and as LV end-
diastolic volume (EDV) increased, RVEDV increased in
the same order of magnitude in both males and females
(R
2 = 0.87, p < 0.001). The authors conclude that total
heart volume is a strong, independent predictor of maxi-
mal work capacity for both males and females, and that
long term endurance training is associated with a
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left and right ventricular dimensions in both genders.
Peak oxygen uptake in relation to total heart volume
discriminates heart failure patients from healthy
volunteers and athletes
The syndrome of heart failure still raises questions, includ-
ing the genesis of exercise intolerance and symptoms [7].
Engblom et al continued their examination of total heart
volume as a parameter related to cardiac function by test-
ing the hypothesis that the peak oxygen uptake to total
heart volume ratio can be used to distinguish patients with
heart failure from healthy volunteers and endurance ath-
letes [8]. They studied 31 patients with various forms of
heart failure, 60 healthy volunteers and 71 athletes and
found that peak oxygen uptake was strongly correlated to
total heart volume in the control subjects, but not for the
patients. In addition, the peak oxygen uptake to total heart
volume ratio differed significantly between control subjects
and patients, and was the only independent predictor of
presence of heart failure (p < 0.001) by multivariable ana-
lysis. The authors conclude that the peak oxygen uptake
to total heart volume ratio may prove useful in early heart
failure diagnosis.
Longitudinally and circumferentially directed movements
of the left ventricle studied by cardiovascular magnetic
resonance phase contrast velocity mapping
Condreanu et al used high resolution CMR to detect new
details of LV systolic and diastolic function, to explain the
twisting and longitudinal movements of the left ventricle
[9]. The authors found that left ventricular function may
be a consequence of the relative orientations and moments
of torque of the sub-epicardial relative to the sub-endocar-
dial myocyte layers, with influence from tethering of the
heart to adjacent structures and the directional forces
associated with blood flow, and conclude that understand-
ing the complex mechanics of the left ventricle is vital to
enable these techniques to be used for the evaluation of
cardiac pathology.
Impact of diastolic dysfunction severity on global left
ventricular volumetric filling - assessment by automated
segmentation of routine cine cardiovascular magnetic
resonance
Mendoza et al examined the relation between the severity
of echocardiography derived diastolic dysfunction and
volumetric filling by automated processing of routine
cine CMR [10]. Automated segmentation was performed
to generate diastolic filling curves from the CMR data.
Comparison with echocardiography finding of diastolic
dysfunction was good. The authors concluded that auto-
mated cine-CMR segmentation can discern LV filling
changes that occur with increasing severity of
echocardiography derived diastolic dysfunction, and that
impaired relaxation is associated with prolonged filling
intervals whereas restrictive filling is characterized by
increased filling rates.
Automated left ventricular diastolic function evaluation
from phase-contrast cardiovascular magnetic resonance
and comparison with Doppler echocardiography
Bollache et al aimed to develop a robust process to auto-
matically estimate velocity and flow rate-related diastolic
parameters from PC-CMR data and to test the consis-
tency of these parameters against echocardiography as
well as their ability to characterize left ventricular (LV)
diastolic dysfunction [11]. The MR diastolic parameters
varied significantly in patients with aortic stenosis as
opposed to controls. Both velocity and flow rate diastolic
parameters were consistent with echocardiography values
(r > 0.71) and receiver operating characteristic (ROC)
analysis revealed their ability to separate patients from
controls, with sensitivity 80%, specificity 80% and accu-
racy 85%. Slight superiority in terms of correlation with
echocardiography (r = 0.81) and accuracy to detect LV
abnormalities (sensitivity 83%, specificity 91% and accu-
racy 89%) was found for the PC-CMR flow-rate related
parameters. The authors conclude that their PC-CMR
technique was fast and reproducible with successful
extraction of consistent velocity-related diastolic para-
meters, as well as flow rate-related parameters. This tech-
nique provides a valuable addition to established CMR
tools in the evaluation and the management of patients
with diastolic dysfunction and builds on the work of
Feng reported in 2009 [12].
Cardiac resynchronization therapy guided by
cardiovascular magnetic resonance
Leyva has been a pioneer of the application of CMR to
guide cardiac resynchronization therapy, and relate the
CMR findings to hard cardiac outcomes. Previous work
published in JCMR includes the visualisation of the coron-
ary venous anatomy to guide wire placement, [13] and
CMR techniques to measure dyssynchrony [14]. This
authoritative state of the art review summarises his work
and that of others in the field [15].
Cardiovascular magnetic resonance in patients with
pectus excavatum compared with normal controls
A number of influences on cardiac function and the elec-
trocardiogram have been reported in JCMR, including
obesity, [16] and athletic training, [17] but the influence of
chest deformity is a new area. Saleh et al contribute a use-
ful paper to the cardiology literature by studying 30
patients with pectus excavatum and determining the
effects of the distorted anatomy on cardiac structure and
function [18]. No significant differences between pectus
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tion fraction, LV myocardial shortening, pulmonary-
systemic circulation time or pulmonary flow indices. In
pectus excavatum, resting RV ejection fraction was
reduced (53.9 ± 9.6% versus 60.5 ± 9.5%; P = 0.013),
RVSD was reduced (P < 0.05) both at end diastole and sys-
tole, RVLD was increased at end diastole (P < 0.05) reflect-
ing geometric distortion of the RV due to sternal
compression. The authors conclude that pectus excavatum
mainly affects the right ventricle.
Flow Evaluation and Valve Disease
The unique capability of CMR to measure cardiovascular
flow is important in the armamentarium of techniques
that contribute to the versatility of CMR. This has great-
est application in valve disease [19,20] but it is also often
used in congenital heart disease, coronary disease and
pulmonary disease [21].
Flow measurement by cardiovascular magnetic
resonance: a multi-centre multi-vendor study of
background phase offset errors that can compromise the
accuracy of derived regurgitant or shunt flow
measurements
The ability to measure the volumes of forward and regur-
gitant flow through planes transecting the aorta and pul-
monary trunk is a unique and clinically valuable capability
of CMR. However, these derived measurements of volu-
metric flow are sensitive to errors caused by small offsets
of the measured velocities, and this has been reported pre-
viously in JCMR [22]. This multi-centre, multi-vendor
study used static phantoms to test for such errors in the
absence of any post-acquisition correction [23]. It found
that all three types of 1.5 Tesla system tested appeared to
require post-acquisition correction to achieve consistently
reliable breath-hold measurements of flow. This high-
lighted the need for continuing work towards the minimi-
zation of such errors, a subject that has subsequently been
investigated further and reported in JCMR [24].
Baseline correction of phase-contrast images in
congenital cardiovascular magnetic resonance
This paper addressed the related subject of post-acquisi-
tion phantom correction of CMR phase contrast flow velo-
city acquisitions on a General Electric 1.5 Tesla system, as
used for aortic, pulmonary and shunt flow measurements
in 149 patients in a clinical congenital CMR program [25].
Phantom correction was found, in many but not all cases,
to result in clinically significant changes in flow measure-
ments, either increased or decreased, without a consistent
directionality to the changes. The study underlines the
value of performing post acquisition phantom correction
of flow measurements in CMR systems with known or
suspected phase offset errors, as has previously been
described in JCMR [26].
Semi-automatic quantification of 4D left ventricular blood
flow
The acquisition, analysis and display of multidirectional
time resolved 3D or 7D flow has been well developed in
JCMR [27]. Eriksson now reports the semi-automated
analysis of CMR 4D flow velocity data for the quantifi-
cation and visualization of flow through the LV in six
normal and three dilated myopathic hearts [28]. The
technique used information on cavity boundaries identi-
fied from short and long axis cine acquisitions together
with the 4D flow velocity data to derive of the volumes,
distributions and timings of selected components of LV
flow. Such an approach may provide a basis for larger
clinical research studies. It illustrates the kind of post
processing software that would help 4D velocity acquisi-
tions to become appealing for use in routine clinical
investigation [29].
Effects of gadolinium contrast agent on aortic blood flow
and myocardial strain measurements by phase-contrast
cardiovascular magnetic resonance
The presence or absence of gadolinium contrast agent in
the blood had no demonstrablee f f e c to np h a s ec o n t r a s t
measurements of aortic flow in this study [30]. Therefore,
when assessing blood flow as well as myocardial viability,
time may be saved by measuring flow after gadolinium
injection and before the acquisition of late gadolinium
enhancement images. Phase-contrast information on
myocardial displacement was also found to be measur-
able with or without contrast agent, but preferably under-
taken pre-gadolinium as that allowed better blood-
myocardial differentiation for appropriate myocardial
segmentation.
Quantification of left ventricular remodeling in response
to isolated aortic or mitral regurgitation
The treatment of patients with aortic regurgitation (AR)
or mitral regurgitation (MR) relies on the assessment of
the severity of the regurgitation as well as its effect on
LV size and function. This study set out to determine
relations between regurgitant volume, measured by
phase contrast velocity mapping, LV volumes and LV
dimensions in patients with isolated AR or MR and pre-
served LV function [31]. It is unsurprising but neverthe-
less important that ventricular volumes were found to
correlate better with regurgitant volume than linear
dimensions. This paper provides valuable data on the
LV volume ranges that correspond to published recom-
mended linear dimensions for guidance on decision
making regarding the timing of surgical intervention for
AR or MR.
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magnetic resonance
Direct anatomical imaging of the valves by CMR, includ-
ing valve morphometry, [32] and regurgitant volumes
[33,34] has become more established. This study set out to
test the feasibility of CMR SSFP cine planimetry to evalu-
ate the orifice area of mitral bioprostheses [35]. Eighteen
consecutive patients, 11 in atrial fibrillation and one with
frequent ventricular ectopics, were studied. The cine
image appearances, the levels of agreement between CMR
and transesophageal echo assessments of orifice area, and
the inter-observer reproducibility of CMR planimetry
measurements together provided at least preliminary sup-
port for the feasibility and potential usefulness of the
CMR approach.
Hemodynamic predictors of aortic dilatation in bicuspid
aortic valve by velocity-encoded cardiovascular magnetic
resonance
Bicuspid aortic valve (BAV) is a common congenital
malformation which, besides its tendency to develop ste-
nosis or regurgitation, predisposes to aortic dilatation
and dissection. Compared to healthy controls, this study
reports the aortic dilatation found in the group of 18
young BAV patients studied and the increased angle
measured between the direction of the left ventricular
outflow stream and the axis of aortic root channel [36].
These two measures were found to correlate with one
another, although the causality remains unresolved.
Plasma levels of matrix metallo-proteinase 2, an extra-
cellular protein considered to be a marker of vessel wall
disease, was also found to correlate with ascending aor-
tic dilatation and the flow jet angle in the groups
studied.
Congenital and pediatric heart disease
Assessment of atrial septal defects in adults comparing
cardiovascular magnetic resonance with
transoesophageal echocardiography
Pre-procedure assessment of maximal and minimal
atrial septal defect (ASD) dimensions and atrial septal
margins was performed by both CMR and transesopha-
geal echocardiography (TOE) in this study [37]. CMR
acquisitions included contiguous stacks of 6 mm thick
SSFP cines in short and long axis orientations across the
ASD region. Measurements by the two modalities
agreed well with one another, so CMR was proposed as
an alternative to TOE for the pre-procedure assessment
of ASDs. It is worth adding that CMR can also provide
reliable information on the amount of shunting and the
presence or absence anomalous pulmonary veins in this
common congenital condition, although these were not
aspects of the study reported.
Right ventricular ejection fraction is better reflected by
transverse rather than longitudinal wall motion in
pulmonary hypertension
In patients with pulmonary hypertension, fractional trans-
verse dimensional shortening, measured from the mid sep-
tal region to the free wall of the RV in a four-chamber
cine, was found to correlate better with RV ejection frac-
tion than the fractional shortening of the long axis of the
RV in this CMR study [38]. The transverse measure is
therefore a potential alternative to tricuspid annular plane
excursion for monitoring RV dysfunction by echocardio-
graphy, or by CMR, in pulmonary hypertension.
Preoperative evaluation of pulmonary artery morphology
and pulmonary circulation in neonates with pulmonary
atresia - usefulness of MR angiography in clinical routine
Contrast-enhanced magnetic resonance angiography (CE-
MRA) was found to be a useful diagnostic tool for the pre-
operative evaluation of the morphology of pulmonary
arteries and blood supply in this retrospective study of 15
neonates with pulmonary atresia [39]. In most cases, the
information provided by CMR was considered sufficient to
avoid the risks of radiation exposure and the potential
complications that are associated with diagnostic cardiac
catheterization.
Truncus arteriosus with aortic arch interruption:
cardiovascular magnetic resonance findings in the
unrepaired adult
CMR findings in an unusual case of a 28 year-old female
patient with unrepaired truncus arteriosus and also inter-
ruption of the aortic arch were illustrated and described in
this report [40].
Cardiomyopathy
The use of CMR in cardiomyopathy has exploded in the
last 5 years and many CMR centres now find cardiomyo-
pathy patients form the largest proportion of the work-
load. The synergy of CMR with cardiovascular genetics
has become clear, as has the need for CMR physicians to
work closely with electrophysiology colleagues in assessing
arrhythmic [41] and sudden death risks. Rare forms of car-
diomyopathy, [42] which may be unclassified, [43-46] are
being studied and common themes of myocardial fibrosis
development, pattern of deposition, and association with
outcomes are being established.
Circumferential myocardial strain in cardiomyopathy with
and without left bundle branch block
Cardiac resynchronization therapy (CRT) has been shown
to improve clinical outcomes in patients with heart-failure.
However, 30-40% of patients who receive CRT therapy do
not show significant clinical improvement. There is much
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t h i ss t u d y ,H a ne ta ls o u g h tt oe x a m i n ec i r c u m f e r e n t i a l
patterns in patients with LBBB and systolic dysfunction by
applying tagged CMR [47]. Septal dyskinesis was as
expected a frequent abnormality. Three main patterns of
abnormality were seen. Some patients with LBBB had
severe mechanical dyssynchrony manifested as a specific
contractile pattern with initial presystolic septal contrac-
tion during isovolumic contraction period followed by dys-
kinesis (positive εcc) of the interventricular septum during
the entire systole. This pattern was present in the antero-
septum (Type Ia) in 30% of patients, and in the entire sep-
tum in 50% of patients (Type Ib). The remaining 20% of
LBBB patients had a normal contractile pattern, similar to
non-LBBB cardiomyopathy patients and healthy controls,
although the magnitude of contraction was significantly
reduced in both groups of cardiomyopathy patients com-
pared to healthy controls. The recognition of the presence
of different mechanical contraction patterns within the
same conduction abnormality may be important for the
selection of patients for CRT.
How do hypertrophic cardiomyopathy mutations affect
myocardial function in carriers with normal wall
thickness? Assessment with cardiovascular magnetic
resonance
HCM is typically due to a sarcomeric gene mutation with
an autosomal dominant pattern of inheritance. As such,
early recognition of functional changes to either recog-
nise gene carriers or as a putative target for therapy
would be advantageous. In this study, Germans et al used
CMR to assess global LA and LV volumes and regional
intramural myocardial function in carriers with normal
wall thickness [48]. The asymmetry in wall thickness
between the septum and lateral wall, which is characteris-
tic for HCM, was already present in some carriers with
normal wall thickness. Typical focal LGE was present in
2 carriers. Also, LA volumes were larger in carriers. In
addition, HCM mutation carriership was identified as an
independent determinant of reduced circumferential
strain and strain rate, which was predominantly present
in the basal lateral segments. Segmental peak systolic cir-
cumferential strain (SCS) and peak diastolic circumferen-
tial strain rate (DCSR) had a high accuracy to identify
carriers, but did not completely exclude HCM mutation
carriership.
Left ventricular T2 distribution in Duchenne Muscular
Dystrophy
Duchenne Muscular Dystrophy (DMD) is associated with
a skeletal and cardiac myopathy, the latter of which is
coming under increasing scrutiny, in humans and animals,
[49] as a cause of death. A better understanding of the
pathobiology and early changes will provide a potential
opportunity to improve management. Significant research
h a sb e e nd o n et oe s t a b l i s har o l eo fT 2r e l a x a t i o nt od e t e c t
myocardial edema, [50,51] and in this study, of 26 Patients
with DMD, Wansapura et al used the Full Width of Half
Maximum (FWHM) of T2 distribution in the LV to quan-
tify the myocardial structural heterogeneity in DMD
patients [52]. In DMD subject groups, FWHM of the T2
histogram rose progressively with age and decreasing EF.
Further, FWHM was significantly higher in those with
reduced circumferential strain. The myocardial structural
abnormality suggested by the observed trend is likely due
to concomitant presence of interstitial fibrosis and so in
the early stage is not detected by the late enhancement
technique. This study supports the view that the regional
dysfunction depicted by reduced circumferential strain is
associated with the ultrastructural myocardial cell
abnormality present in DMD patients.
Quantitative analysis of late gadolinium enhancement in
hypertrophic cardiomyopathy
The presence and amount of fibrosis in HCM appears to
portend an adverse prognosis. An important practical
challenge however has been defining and quantifying the
presence of myocardial fibrosis by the late enhancement
technique. Several methods based on a standard devia-
tion or a full-width half maximum method have been
proposed. Whilst these are highly reproducible in an
infarct setting, in HCM where the fibrosis is more patchy
and often diffuse, there is often the challenge of distin-
guishing true fibrosis from noise. In this study, Donato
Aquaro and colleagues describe the merits of a cut-off
derived from a Rayleigh curve as being potentially more
accurate than using a fixed cut-off using a standard
deviation algorithm [53]. Further work is required to
compare this to other algorithms based on a full-width
half maximum method.
Right ventricular volumes and function in thalassemia
major patients in the absence of myocardial iron
overload
Beta-thalassemia major (TM) is a severe hereditary anemia
requiring lifelong transfusions. There is a consequent iron
overload, predominantly affecting the heart, liver and
endocrine organs. Iron overload cardiomyopathy remains
a major cause of death and therefore early detection of
iron-induced cardiac toxicity is important, following by
iron chelation treatment tailored to the heart [54]. In addi-
tion to measurement of myocardial T2*, ventricular func-
tion can be impaired. Much of the current work has
focused on the LV, however it is well established that RV
dysfunction heart-failure carries an adverse prognosis. In
this study, Carpenter and colleagues extended work evalu-
ating the LV, to define a reference range for RV volumes,
ejection fraction (EF) in thalassemia major patients (TM)
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tant in assessing the impact of myocardial iron overload in
this cohort of patients and in assessing response to
treatment.
Early detection of cardiac involvement in Miyoshi
myopathy: 2D strain echocardiography and late
gadolinium enhancement cardiovascular magnetic
resonance
The first question raised by this title must be -’so what is
Miyoshi myopathy’? Miyoshi Myopathy (MM) is a distinct
form of muscular dystrophy caused by mutations within
the dysferlin (DYSF) gene resulting in severe to complete
deficiency of dysferlin expression. Clinically, these dysferli-
nopathies start in young adulthood with progressive mus-
cle weakness and atrophy that advances to severe disability
in older adulthood. While the profound effect of dysferlin
deficiency in skeletal muscle has been the subject of much
investigation, the effect of dysferlin deficiency in cardiac
muscle have not been studied yet. In this study, Choi et al,
demonstrated a reduction in longitudinal strain and the
presence of replacement fibrosis in a subset of affected
patients [56]. This was detected prior to the development
of cardiovascular symptoms or a reduction in overall
LVEF. The ramifications are two-fold. Firstly in this
uncommon myopathy demonstrating an opportunity for
early detection. Secondly and more broadly, it extends the
‘portfolio’ of cardiomyopathies where CMR in conjunction
with echo provides unique insights based on tissue
characterization.
Troponin release following endurance exercise: is
inflammation the cause? A cardiovascular magnetic
resonance study
It is generally acknowledged that exercise is a good thing.
Yet debate persists about the true health benefits of ultra-
endurance forms exercise - particularly marathon running
where a troponin rise is seen - often to the same levels as
an acute myocardial infarction. In this study, O’Hanlon
and colleagues examined if there were detectable tissue
changes on CMR in a cohort of volunteers scanned follow-
ing a marathon [57]. A baseline control scan pre-exercise
was performed in all participants. Exercise induced cardiac
biomarker release was not associated with any functional
changes by CMR or any detectable myocardial inflamma-
tion or fibrosis. This study contributes to understanding
the link, aetiology and significance of the troponin rise
post-exercise.
Epicardial adipose tissue in patients with heart failure
The role of epicardial adipose tissue (EAT) and its contri-
bution to the development of cardiac pathology is quite
ambiguous. There is growing evidence of a close func-
tional and anatomical relationship between the adipose
tissue and muscular components of the heart. Its close
proximity to the myocardium suggests that EAT is a
metabolically active organ and a source of several bioac-
tive molecules may influence cardiac morphology and
function. In this study, Doesch et al demonstrate that in
patients with CHF and severely reduced impaired LV-EF
(LV-EF < 35%), EAT is significantly reduced compared to
healthy controls [58]. The reduction of EAT is irrespec-
tive of the underlying aetiology of the cardiomyopathy.
Like in healthy controls an increase in left ventricular
mass also leads to an augmentation of the EAT mass in
patients with CHF, however, contrary to previous studies,
the EAT mass/LV-EDM ratio is significantly lower com-
pared to healthy controls. Abnormalities and/or anatomic
alterations due to disturbed cardiac function and geome-
try seem to play a key role and are a possible explanation
for these findings.
Myocardial late gadolinium enhancement cardiovascular
magnetic resonance in patients with cirrhosis
End stage liver disease (ELD) is associated with major
alterations in the regulation of the cardiovascular system.
Portal hypertension and/or hormonal changes in ELD
induce a hyperdynamic circulatory state characterized by
arterial hypotension and tachycardia and are often accom-
panied by ascites and electrolyte disturbances. Recent data
also emphasizes the impact of liver function on renal
(hepatorenal syndrome) and pulmonary (hepatopulmonary
and portopulmonary syndrome) circulation. Whilst there
is much focus on the causes and treatment of renal and
pulmonary manifestations, relatively little is understood
about the myocardial changes as a result of ELD. In this
study, Lossnitzer et al show that myocardial alterations
have a high prevalence among ELD patients [59]. This is
often in a pattern seen in myocarditis. Commonly identi-
fied features were a hyperdynamic LV function and a pat-
chy pattern of replacement fibrosis. This work is useful in
furthering our understanding of the effects of severe liver
disease and may have potential value in guiding selection
of Patients for liver transplantation - the latter needs larger
prospective trials.
Accuracy of cardiovascular magnetic resonance in
myocarditis: comparison of MR and histological findings
in an animal model
In the evaluation of myocarditis, CMR has now fre-
quently replaced the more traditional method of endo-
myocardial biopsies (EMB) to confirm the diagnosis. As
well as being invasive and with a tangible risk of severe
morbidity or mortality, EMB has frequently suffered from
sampling bias resulting in a low sensitivity. In an animal
model, the extent of LGE correlated to the histological
severity of myocarditis and to serum-levels of troponin T
on day 21 [60]. Areas of LGE had nearly identical
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proven areas of inflammation and provided a good mar-
ker of cardiomyocyte necrosis. This is supportive data for
the clinical use of CMR either as an alternative to EMB,
or where it is important to know the pathogen, to guide
the site of EMB.
Myocardial fibrosis in desmin-related hypertrophic
cardiomyopathy
Desmin is the main intermediate filament protein
expressed in skeletal, cardiac, and smooth muscle. It inter-
acts with other proteins to form a continuous cytoskeletal
network that maintains a spatial relationship between the
contractile apparatus and other structural elements of the
cell, thus providing maintenance of cellular integrity, force
transmission, and mechano-chemical signalling. Primary
desminopathies are caused by mutations in the desmin
gene. This disease is characterized by an intracellular accu-
mulation of insoluble protein aggregates eventually leading
to cell death and replacement fibrosis. In this case report,
fibrosis was detected by LGE in the absence of global or
focal systolic wall motion abnormalities [61]. LGE may
have value therefore in the diagnosis and early evaluation
of affected individuals.
Atheroma and Vascular
Many experts consider that CMR will play an increasing
role in characterisation of the atherosclerotic arterial
wall, [62] with a focus on early detection, monitoring of
response to treatment, [63] and relation to outcomes,
[64] rather than a slavish attention of stenosis detection
for which other techniques are widely used. Vessel wall
CMR, [65,66] and angiography, [67,68] seem to clearly
benefit from the use of 3 T. The papers in this section
illustrate the variety of ways that CMR can be used to
investigate vascular disease.
Variations in atherosclerosis and remodelling patterns in
aorta and carotids
This is an interesting study that attempts to examine
atherosclerosis progression and regression in multiple
vascular beds (thoracic aorta, abdominal aorta and caro-
tids) of 28 patients using black blood CMR over a one
year period [69]. Luminal and wall areas were measured.
Results of this study indicate that different vascular loca-
tions exhibited varying progression of atherosclerosis
and remodelling as monitored by CMR. However there
are a number of important limitations to be noted
including the retrospective nature of the analysis on a
small number of patients, and plaque burden was mea-
sured across the entire artery and not within specific
plaque. Other limitations are linear model and not mul-
tivariate regression analysis was used.
Thoracic aortopathy in Turner syndrome and the
influence of bicuspid aortic valves and blood pressure:
a CMR study
This is an observational, cross-sectional study of aortic
dimensions within a large, unselected cohort of adult
patients with Turner’s syndrome (TS) [70]. As such, this
study gives important and valuable “normal” data for this
specific cohort, and describes prominent risk factors for
abnormal aortic dimension. A higher incidence of aortic
valve disease, aortopathy, aortic coarctation and dissection
has been well-described in multiple prior population stu-
dies. The current manuscript, however, attempts to more
rigorously describe the size characteristics of a “general
population” of TS patients in comparison to a control
group - utilizing both CMR techniques and echocardiogra-
phy. Overall, the study provides important information in
a systematic fashion, and adds to the literature of TS cen-
tral aortic disease.
Ultra-short echo time cardiovascular magnetic resonance
of atherosclerotic carotid plaque
This small ex vivo study examines the feasibility of detect-
ing carotid plaque calcification using an ultra-short TE
(UTE) technique [71]. Fourteen ex-vivo human plaques
with UTE MR, CT and histology and found a reasonable
agreement among the three approaches for calcification
identification. The authors also noticed a certain amount
of false positive readings from UTE MR when compared
to CT and histology. Although the authors identified a
certain degree of agreement between UTE and histology,
no definite conclusion could be drawn without supporting
quantitative comparisons. Another concern is the possible
mismatch between MR, CT and histology.
Measuring aortic pulse wave velocity using high-field
cardiovascular magnetic resonance: comparison of
techniques
The authors quantitatively compare three different
approaches for aortic pulse wave velocity measurements
at 3 T including transit time, flow area measurements
and the cross correlation method [72]. Fifty heterogenous
patients and 6 healthy volunteers were scanned and the
inter-observer, intra-observer and the study-restudy
v a r i a b i l i t yw e r er e p o r t e d .Each method has advantages
and limitations but no bias among the three methods was
found although the flow area method was found to be the
least reproducible.
Natural history of spontaneous aortic intramural
hematoma progression: Six years follow-up with
cardiovascular magnetic resonance
This is an interesting case report on the natural history
and evolution of spontaneous intramural haematoma
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ture review [73]. The IMH followed for 6 years by CMR
imaging. The patient progressed through different
stages, including hematoma absorption, ulcer-like lesion
emergence, aneurysm enlargement and limited aortic
dissection.
The association of lesion eccentricity with plaque
morphology and components in the superficial femoral
artery: a high-spatial-resolution, multi-contrast weighted
CMR study
The authors describe the association between atheroma-
tous plaque eccentricity with morphology and composi-
tion in the superficial artery assessed by multicontrast
weighted-CMR [74]. The study involved 28 subjects and
180 diseased segments. All patients had an ankle-brachial
index < 1.00. The authors concluded that eccentric
lesions were larger despite having similar luminal area. In
addition, they contained larger lipid rich necrotic core
and more calcification. The study is of interest but is lim-
ited by being observational with low number of patients
and significant variability in PAD severity.
Regional in vivo transit time measurements of aortic
pulse wave velocity in mice with high-field CMR at
17.6 Tesla
This study describing a phantom and mouse set of experi-
ments validating the transit time method by MR phase
velocity encoding for measuring pulse wave velocity using
17.6 T scanner [75]. The authors show validation of the
method in the phantom and that PWV is higher in APO-
E KO mice than controls. Transgenic mouse models are
increasingly used to study the pathophysiology of human
cardiovascular diseases. The aortic pulse wave velocity
(PWV) is an indirect measure for vascular stiffness and a
marker for cardiovascular risk.
Right coronary wall CMR in the older asymptomatic
advance cohort: positive remodelling and associations
with type 2 diabetes and coronary calcium
CMR Black blood coronary wall imaging was used in 223
elderly patients without known history of cardiovascular
disease to evaluate coronary wall CMR in an asympto-
matic older cohort [76]. Image quality was fair or good in
67% of patients allowing for assessment of vessel, wall and
lumen area as well as vessel wall thickness in 150 subjects.
Multivariate analysis showed association between total/
HDL cholesterol ratio and wall thickness as well as
between diabetes and vessel area and wall thickness.
Furthermore, the authors report significant correlation
between calcium score, vessel area, wall area, and wall
thickness. Bland-Altman analysis demonstrated only small
differences for inter and intra-observer measurements of
vessel area, wall area, and lumen area. The authors
conclude that coronary wall CMR may contribute to the
non-invasive assessment of subclinical coronary athero-
sclerosis in older, at-risk patient groups.
Perfusion
Perfusion CMR continues to grow, and new steps in
optimisation have been published including accelerated
acquisition, high field CMR, and improved analysis
including quantification. In many centres, perfusion
CMR is making inroads into established referral patterns
for nuclear based techniques. Progress in perfusion
CMR in children and women in particular has occurred
in a desire to lower radiation burden in these sensitive
individuals [77]. However there remains room for
improvements in ease of analysis and quantification,
artefact elimination, [78] robustness and relation to out-
comes [79].
Evaluation of contrast wash-in and peak enhancement in
adenosine first pass perfusion CMR in patients post
bypass surgery
Kelle et al performed perfusion CMR on 38 patients after
coronary bypass grafting (CBG) without coronary obstruc-
tion and compared the results with 20 patients with no
obstructive coronary disease at coronary angiography to
determine whether differences in epicardial wash-in
kinetics were present [80]. In areas perfused by coronary
arteries with bypasses compared to native coronaries, the
time for contrast to reach maximum in native coronaries
and bypasses was 12.6 s ± 3.0 s vs 13.1 s ± 3.0 s (p < 0.05),
respectively. The delay in Tmax resulted in a significant
(p < 0.05) delay of 0.5 ± 1.1 heart beats (= images) when
adjusted to the heart rate. Differences in time were most
pronounced in areas perfused by left internal mammary
artery grafts rather than by venous CBG, but were also pre-
sent between native vessel territories in patients without
CAD, albeit with smaller variability. The authors conclude
that adenosine perfusion CMR in patients post CBG may
be associated with a short delay in contrast arrival, but that
this does not seem to be a limiting factor for the accuracy
of first pass adenosine perfusion in patients post CBG.
Meta-analysis of the diagnostic performance of stress
perfusion cardiovascular magnetic resonance for
detection of coronary artery disease
Hamon et al performed a meta-analysis of the perfor-
mance of perfusion CMR summarising 35 original arti-
cles fitting pre-specified inclusion criteria including 1.5 T
imaging and comparison with coronary angiography [81].
From the 263 citations identified, 55 relevant original
articles were selected. The overall patient-based analysis
demonstrated a sensitivity of 89% (95% CI: 88-91%), and
a specificity of 80% (95% CI: 78-83%). Adenosine stress
perfusion CMR had better sensitivity than with
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0.022), and a tendency to a better specificity (81% (78-
84%) versus 77% (71-82%), P = 0.065). The authors con-
clude that perfusion CMR is highly sensitive for detection
of CAD but its specificity remains moderate.
Real-time cine and myocardial perfusion with treadmill
exercise stress cardiovascular magnetic resonance in
patients referred for stress SPECT
Raman et al performed an unusual and interesting perfu-
sion CMR study, using treadmill stress and real-time CMR
in a cohort of 43 patients referred for perfusion SPECT
[82]. Using an ingenious protocol of technetium injection
at peak exercise and CMR immediately post-exercise they
were able to complete the real-time CMR in 88 seconds
with only a 68 second delay after exercise. Agreement
between SPECT and CMR was moderate ( =0 . 5 8 ) .A c c u -
racy in eight patients who underwent coronary angiogra-
phy was 7/8 for CMR and 5/8 for SPECT (p = 0.63).
Follow-up at 6 months indicated freedom from cardiovas-
cular events in 29/29 CMR negative and 33/34 SPECT-
negative patients. The authors conclude that exercise
stress CMR including wall motion and perfusion is feasible
in patients with suspected ischemic heart disease and that
further trials may be warranted.
Reproducibility of adenosine stress cardiovascular
magnetic resonance in multi-vessel symptomatic coronary
artery disease
Chih et al performed an important study examining the
interstudy reproducibility (test-retest repeatability) of ade-
nosine stress perfusion CMR in 20 patients (10 with coron-
ary disease and 10 at low risk for coronary disease) [83].
The CoV for the number of ischemic segments was 31%
with a mean difference of -0.15 ± 0.88 segments and 91%
perfect agreement between studies. The reproducibility of
MPRi was 19% with no significant difference between
patients with CAD and those with low risk CAD (p =
0.850). For trials using perfusion CMR as an endpoint, an
estimated sample size of 12 subjects would be required to
detect a two-segment change in the number of ischemic
segments (power 90%, a 0.05). The authors conclude that
adenosine stress CMR, by qualitative and semi-quantitative
normalized upslope analyses are reproducible techniques
in both patients with multi-vessel CAD and those without
known CAD. The robust inter-study reproducibility of per-
fusion CMR supports its clinical and research application.
Quantification of myocardial perfusion using CMR with a
radial data acquisition: comparison with a dual-bolus
method
Kim et al explored the use of radial data acquisition at
3 T for quantification of perfusion CMR [84]. Using a
dual bolus approach, the arterial input function (AIF)
was calculated from the blood signal in three sub-
images with differing effective saturation recovery times
(SRT). The full and sub-images were reconstructed
iteratively with a total variation constraint. The images
from the full 72 ray data were processed to obtain tissue
enhancement curves. A 2-compartment model was used
to determine absolute flows. The proposed multi-SRT
method resulted in AIFs that were similar to those
obtained with the dual-bolus method. The authors con-
clude that the multi-SRT method with a radial k-space
perfusion sequence, can be used to obtain an accurate
AIF and thus quantify myocardial perfusion for doses of
contrast agent that result in a relatively saturated AIF.
Quantification of myocardial perfusion by cardiovascular
magnetic resonance
Jerosch-Herold has pioneered many aspects of perfusion
CMR, and in this authoritative review he summarises the
quantification of myocardial perfusion using first pass
techniques [85]. The potential of contrast-enhanced car-
diovascular magnetic resonance (CMR) for a quantitative
assessment of myocardial perfusion has been explored
for more than a decade, with encouraging results from
comparisons with accepted “gold standards”,s u c ha s
microspheres used in the physiology laboratory. This has
generated an increasing interest in the requirements and
methodological approaches for the non-invasive quantifi-
cation of myocardial blood flow by CMR. The field has
reached a stage, where quantification of myocardial per-
fusion is no longer a claim exclusive to nuclear imaging
techniques. CMR may in fact offer important advantages
like the absence of ionizing radiation, high spatial resolu-
tion, and an unmatched versatility to combine the inter-
rogation of the perfusion status with a comprehensive
tissue characterization. Further progress will depend on
successful dissemination of the techniques for perfusion
quantification among the CMR community.
Nasal continuous positive airway pressure improves
myocardial perfusion reserve and endothelial-dependent
vasodilation in patients with obstructive sleep apnea
Nguyen et al studied whether obstructive sleep apnoea
(OSA) as a risk factor for coronary artery disease, by
measuring myocardial perfusion and brachial artery reac-
tivity in a randomised controlled study of 35 OSA
patients randomised to 3 months of nasal continuous
positive airway pressure (nCPAP) or sham nCPAP [86].
Patients on nCPAP showed improved perfusion and vas-
cular reactivity compared to those on sham treatment.
The authors conclude that that relief of apnea in OSA
may improve microvascular disease and endothelial dys-
function, which may prevent the development of overt
cardiovascular disease, and that further study in a larger
patient population, may be warranted.
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cardiovascular magnetic resonance
Karamitsos et al studied the use of high-dose adenosine
for perfusion CMR in patients who showed no haemody-
namic response to adenosine at the normal dose of
140 ug/kg/minute [87]. In a study of 98 patients, 18 satis-
fied the entry criteria for response failure and the infusion
dose was increased to 210 ug/kg/min at which point 16 of
the 18 patients showed a response. The authors concluded
that increased age or reduced ejection fraction were pre-
dictors of non-response, and presumably undisclosed
drinking of caffeine was also a possibility. The study was
not large enough to examine effects on diagnostic accu-
racy but a further trial might address this issue.
Acute Coronary Syndrome
Increased research in acute coronary syndromes has been
driven by the ability of CMR to look at a number of phe-
nomena that are difficult or impossible to image by other
in-vivo techniques. This includes microvascular obstruc-
tion, myocardial edema, myocardial salvage and relation of
findings to wall motion [88]. There is optimism that this
will translate into clinical trials of adjuvant therapies to
standard primary percutaneous coronary intervention.
Staged cardiovascular magnetic resonance for differential
diagnosis of Troponin T positive patients with low
likelihood for acute coronary syndrome
Troponin biomarkers are very sensitive of myocardial
infarction but patients sometimes present with an elevated
troponin in the setting of inconclusive symptoms and
ECG-changes. Confirmation of acute coronary syndrome
(ACS) or accurate non-ACS diagnosis is of paramount
importance to avoid unnecessary invasive procedures and
to guide therapy. Steen et al reported on the role of CMR
in 29 such patients with elevated troponin yet low-inter-
mediate probability of IHD [89]. A comprehensive succes-
sive eight-step CMR (cine, perfusion, T2 weighted (T2w),
pulmonary angiography, and late gadolinium enhancement
(LGE) was performed at 1.5 T and characterized 93% of
the elevated troponin cases - including 38% with ACS, 21%
with pulmonary embolism, 17% with myocarditis.
Cardiovascular magnetic resonance of the myocardium
at risk in acute reperfused myocardial infarction:
comparison of T2-weighted imaging versus the
circumferential endocardial extent of late gadolinium
enhancement with transmural projection
The use of CMR for identification of myocardium at risk
(MaR), the myocardium supplied by the occluded vessel
that is subject to ischemia has received considerable
recent attention. Ubachs et al compared short-axis triple
inversion turbo spin echo T2w imaging with LGE for
assessment of MaR in 37 patients with early reperfused
first-time ST segment elevation myocardial infarction
(STEMI) within a week of percutaneous coronary inter-
vention [90]. T2w MaR was nearly 50% greater than MaR
derived from LGE, with only a modest correlation of the
methods. As a result, myocardial salvage derived from
T2w imaging was similarly greater.
Assessment of myocardium at risk with contrast
enhanced steady-state free precession cine cardiovascular
magnetic resonance compared to single-photon emission
computed tomography
In another ACS study, Sorensson et al studied MaR
derived from the contrast enhanced cine steady-state-free
precession (SSFP) CMR compared with single photon
emission computer tomography (SPECT) as the gold
standard [91]. Sixteen patients with STEMI due to a total
coronary occlusion were studied. Prior to opening the
occluded vessel, patients received 99mTc tetrofosmin
with imaging performed within 4 hours. CMR was per-
formed within a week with gadolinium-DTPA adminis-
tered before acquisition of short-axis SSFP cines.
Contrast enhanced myocardium in SSFP cines was
manually segmented. There was a very good correlation
(r2 = 0.78) with very small (0.5 +/- 5.1%) difference
between methods. An obvious advantage of the post-Gd
cine SSFP method is that it does not require a second
focused sequence.
Relationship of dysglycemia to acute myocardial infarct
size and cardiovascular outcome as determined by
cardiovascular magnetic resonance
Mather et al applied LGE CMR to examine the impact
of dysglycemia on acute myocardial infarction (AMI)
size in 93 patients presenting with their first AMI [92].
Patients with dysglycermia (admission blood glucose ≥
7.8 mmol/l but < 11.1 mmol/l) as well as those with dia-
betes mellitus (prior history or admission glucose ≥ 11.1
mmol/l) were more likely to have near (> 75%) trans-
mural infarcts, both during the index admission and at a
median follow-up of 11 months. Early LGE evidence of
microvascular obstruction and left ventricular ejection
fraction (LVEF) were similar.
Differentiation of acute and four-week old myocardial
infarct with Gd(ABE-DTTA)-enhanced CMR
Kirschner et al used a novel CMR contrast agent gadoli-
nium, Gd (ABE-DTTA), to differentiate acute vs.
chronic (one month old) myocardial infarction in a dual
infarction canine model [93]. Gd ABE-DTTA) led to
enhancement of only the acute infarction, whereas con-
ventional Gd-DTPA was associated with enhancement
of both acute and chronic infarcts.
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Since the seminal clinical publication by Kim et al over a
decade ago, [94] LGE CMR has played an increasing role
in the management of chronic IHD. The use of LGE has
transformed the investigation and clinical practice of
chronic coronary disease, and yielded considerable new
insights into infarction [95,96]. Work is still progressing
on how best to quantify LGE in relation to outcome, [97]
and the relative merits versus dobutamine stress CMR
[98]. The JCMR papers presented examine important
aspects of this field.
Prediction of global left ventricular functional recovery in
patients with heart failure undergoing surgical
revascularisation, based on late gadolinium enhancement
Cardiovascular Magnetic Resonance
Pegg et al extended this work by examining whether viable
or the sum of viable plus normal segments best predicted
recovery of global LVEF in 33 patients undergoing coron-
ary artery bypass grafting (CABG) [99]. Overall, LVEF
improved from 38 to 47%, but the only independent pre-
dictor for and LVEF improvement of ≥ 3% was the num-
ber of viable plus normal segments. Receiver operator
characteristic analysis demonstrated that at least 10 viable
plus normal segments best predicted an LVEF improve-
ment of ≥ 3%.
Relation between regional and global systolic function in
patients with ischemic cardiomyopathy after b-Blocker
therapy or revascularization
Novel insights into the mechanism of ventricular remodel-
ling to betablocker and mechanical revascularization were
reported by Kaandorp et al who studied 32 patients with
chronic IHD before and 8 months after assignment to
betablocker or revascularization therapy [100]. In both
groups, resting LVEF improved and LV end-systolic
volume declined. However, stepwise multivariate analysis
demonstrated that LVEF improvement in the betablocker
group was related to improved function of remote myocar-
dium, whereas in the revascularized group, improved func-
tion was noted in the dysfunctional and adjacent regions.
Improvement of myocardial perfusion reserve detected
by cardiovascular magnetic resonance after direct
endomyocardial implantation of autologous bone marrow
cells in patients with severe coronary artery disease
CMR has been used to monitor the success of stem cell
treatment in animals, [101] but human use in clinical
trials has been sparse with mixed results. Chan et al used
CMR methods to examine LVEF and myocardial perfu-
sion reserve in 12 patients with chronic IHD after autolo-
gous bone marrow cell implantation [102]. An average of
16 injections per patient were performed. Patients rando-
mized to receive bone marrow cell injection had a
significant decrease in the peri-infarct region and an
increase in regional wall thickening, global LVEF, and
myocardial perfusion reserve over the target area at
6 months.
The 20 year evolution of dobutamine stress
cardiovascular magnetic resonance
A highlight of the 2010 JCMR publications was an com-
prehensive review of dobutamine stress CMR by Charoen-
panichkit and Hundley, a pioneer and ongoing leader in
the field [103]. The review provides comprehensive infor-
mation for the novice and expert stress CMR practitioner
regarding pharmacology, safety, protocols/methods, clini-
cal applications, accuracy, and outcome data.
Electrophysiology and Interventional
Extent of late gadolinium enhancement detected by
cardiovascular magnetic resonance correlates with the
inducibility of ventricular tachyarrhythmia in hypertrophic
cardiomyopathy
Fluechter et al investigated the role of myocardial fibrosis
detected by late gadolinium-enhancement (LGE) CMR as a
potential arrhythmogenic substrate in 76 consecutive
patients with HCM [104]. Of these patients, 43 had 1 or
more risk factors for sudden cardiac death and were there-
fore clinically classified as high-risk patients. Of these
43 patients, 38 additionally underwent an electrophysiolo-
gical (EP) testing. The high-risk patients had a significant
higher prevalence of LGE than low-risk patients (67% vs
47%; p = 0.03). Also the % of LV mass with LGE was signif-
icantly higher in high-risk patients than in low-risk patients
(14% vs 3%, p = 0.001). Of the 38 high-risk patients, 12 had
inducible VT and these patients had significantly higher %
LGE (22% vs 10%, p = 0.03, but LGE prevalence was com-
parable between HCM patients with and those without
inducible VT (83% vs 58%; p = 0.12). In the univariate ana-
lysis the % of LV mass with LGE and the septal wall thick-
ness were significantly associated with the high-risk group
(p = 0.001 and 0.004, respectively). Multivariate analysis
demonstrated that the extent of LGE was the only indepen-
dent predictor of the risk group (p = 0.03). The authors
conclude that the extent of fibrosis may serve as potential
arrhythmogenic substrate for the occurrence of VT, espe-
cially in patients with clinical risk factors for SCD
Towards real-time cardiovascular magnetic resonance-
guided transarterial aortic valve implantation: In vitro
evaluation and modification of existing devices
Cardiovascular magnetic resonance (CMR) is attractive
for real-time device placement and intervention, [105]
but solutions for heating and metallic artefacts are
needed [106]. CMR might be an attractive alternative
for guiding transarterial aortic valve implantation
(TAVI) featuring unlimited scan plane orientation and
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device visualization. Kahlert et al sought to evaluate the
CMR characteristics of both currently commercially
available transcatheter heart valves (Edwards SAPIEN™,
Medtronic CoreValve
®) and a custom-built, CMR-com-
patible delivery device for the Medtronic CoreValve
®
prosthesis as an initial step towards real-time CMR-
guided TAVI [107]. The devices were systematically
examined in phantom models on a 1.5 T scanner using
high resolution T1-weighted 3D FLASH, real-time True-
FISP and flow-sensitive phase-contrast sequences. Major
susceptibility artifacts were present for the 2 commercial
delivery devices precluding in-vivo application. By con-
trast, the nitinol-based Medtronic CoreValve
® prosthesis
was well visualized with good visualization during cathe-
ter movement and valve deployment on real-time True-
FISP imaging. Reliable flow measurements could be
performed for both stent-valves after deployment using
phase-contrast sequences. The authors conclude that
the novel prosthesis is potentially suited for real-time
CMR-guided placement in vivo after suggested design
modifications of the delivery system.
Technical advances and new techniques
The editors of JCMR continue to support publication of
new CMR techniques and the recent review on diffusion
spectral imaging (DSI) with application to tractography
of ex vivo animal hearts proved very popular [108]. The
new techniques described in this section are of interest
especially to the CMR physics community for transla-
tion into robust new human tools.
Deformation analysis of 3D tagged cardiac images using
an optical flow method
Myocardial tagging still presents technical challenges in
implementation and analysis [109,110]. This study
describes a method for measuring strain using MR imaging
with tags in three dimensions coupled to analyses based on
optical flow [111]. The initial part of the study involved
imaging an ex vivo sheep’s heart, the images of which were
processed to introduce tags and known motion. These
images with their known motion were then used to validate
the optical flow motion measurement. These motion simu-
lations were used to optimise the required tag space and
angles for the later in vivo validation. Optical flow motion
estimates obtained in vivo by 3D tagging during systole
were validated by comparison with more conventional ana-
lysis and measurements of myocardial strain.
Analytical method to measure three-dimensional strain
patterns in the left ventricle from single slice
displacement data
The paper describes a means of estimating the full 3D
strain tensor from a slice displacement encoded in three
orthogonal directions, and including assumptions about
the through-plane shear components and compressibil-
ity of the tissue [112]. The analytical method estimates
the out-of-plane as well as the in-plane components of
the Lagrangian strain tensors of the myocardium from
time series of MR images containing only one slice. The
goal of this technique is to reduce the amount of data
acquisition when calculating the strains from cardiac
image. Various tests of the method are performed for
the validation of the method, both on simulated and
real data. The behaviour of the technique with regard
with the noise level is presented. The feasibility of the
method is demonstrated in a healthy human subject and
the results are compared to those of other studies.
Real-time cardiovascular magnetic resonance at high
temporal resolution: radial FLASH with nonlinear inverse
reconstruction
This paper demonstrates initial results of an approach pro-
viding real-time CMR, the data from which can be retro-
spectively reconstructed to provide high resolution [113].
The method uses undersampled radial FLASH at 3 T with
non-linear inversion reconstruction. Image acquisition
times were as short as 20 to 30 ms. With potential future
increases in processing speed this method promises to
enable spectacularly high spatial temporal resolution ima-
ging for a range of cardiovascular applications.
Accelerated cardiovascular magnetic resonance of the
mouse heart using self-gated parallel imaging strategies
does not compromise accuracy of structural and
functional measures
The huge increase in the development of transgenic
mouse models has made mouse phenotyping an increas-
ingly important topic, and basic issues such as sedation
and anaesthesia can affect these tiny hearts [114]. In this
manuscript, self-gating and parallel imaging (SENSE)
techniques were combined to reduce scan time in retro-
spectively gated mouse heart CMR at 4.7 T [115].
Although well-established in humans, parallel imaging in
rodents is much less developed because of their very high
heart-rates, intrinsic low SNR and the limited availability
of phased-array coils. Both healthy and infarcted mice
were subjected to cine-MRI using different acceleration
factors (i.e. 1-3). Left ventricular volumes and functional
parameters obtained from accelerated data sets were
compared to fully sampled reference data. Results
revealed only minor differences in image quality of short-
and long-axis cardiac cines: small anatomical structures
were accurately detected even for 3-fold accelerated data
acquisition using a four-element phased array coil. The
authors concluded that the accuracy of structural and
functional parameters of the mouse heart was not
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ated data acquisition method.
An isolated perfused pig heart model for the
development, validation and translation of novel
cardiovascular magnetic resonance techniques
This article by Schuster et al is of significant interest to the
CMR community [116]. While perfused heart models have
been widely used for metabolic studies, using MRI spec-
troscopy, the same is not true for imaging applications. A
newly developed isolated pig heart model will open impor-
tant new avenues of validating novel CMR sequences (eg.
absolute myocardial blood flow quantification) and will
allow testing of novel treatment strategies (e.g. ischaemia
reperfusion injury interventions). The authors describe
this heart model to be stable and illustrate it’s use on both
1.5 and 3 T clinical scanners. Numbers were small in this
pilot study but there appears to be a very good agreement
between CMR measures of blood flow and late gadolinium
enhancement following selective alterations of coronary
blood flow, which fits with the absence of coronary collat-
erals in the pig heart.
BOLD cardiovascular magnetic resonance at 3.0 Tesla in
myocardial ischemia
This paper describes a novel approach to detect stress-
induced myocardial ischemic reaction using CMR T2* at
3 T in patients with suspected or known coronary artery
disease (CAD) [117]. With quantitative coronary angiogra-
phy as the reference standard, this study demonstrated
the feasibility of myocardial T2* measurement at 3 T to
differentiate between ischemic, non-ischemic, and normal
myocardial segments in a small patient population. In con-
clusion, the authors stated that Stress T2* at 3 T was cap-
able of identifying patients with significant CAD.
Cardiovascular magnetic resonance at 3.0 T: Current state
of the art
This manuscript represents a useful review of the appli-
cation of 3 T CMR and how this differs from 1.5 T
[118]. It is well written and complete particularly with
regard to the clinical applications, adopts a top-level
approach to the physics and overall provides a balanced
perspective. As might be expected there is little in the
way of conclusions except that 3 T is good for some
things, but typically has more artefacts.
Elasticity-based determination of isovolumetric phases in
the human heart
In this paper, the authors present an investigational
study on a potential application of MR-Elastography
(MRE) in cardiology, [119] and the data continues to
develop previously published work in this area in JCMR
[120]. The method attempts to quantify time delays
associated with isovolumetric tension and relaxation
based on delays between volume-time and shear wave
amplitude-time curves. The isovolumetric tension time
was shown to be statistically significantly longer in those
patients with known myocardial relaxation abnormal-
ities. The hope is that this time will prove to be corre-
lated to disease stage and type and therefore this could
have a significant impact both in terms of diagnosis but
also monitoring of patients with those cardiac diseases
which are known to induce changes in myocardial
stiffness.
Acoustic cardiac triggering: a practical solution for
synchronization and gating of cardiovascular magnetic
resonance at 7 Tesla
This paper describes the use of the acoustic sensing
approach to gating CMR data acquisitions [121]. The
method is applied at 7Tesla where ECG gating can be
challenging, and compares this new acoustic approach
with the well proven vector ECG and Pulse-oxymetry
methods. Standard parameters including end-systolic
volume (ESV), end-diastolic volume (EDV), ventricular
mass and ejection fraction as well as subjective scores of
i m a g eq u a l i t ya r ec o m p a r e df o rt h et h r e et r i g g e r i n g
methods in healthy subjects. Results indicate that the
acoustic method is an improvement over ECG and offers
some advantages of Pulse-oxymetry and that it provides a
feasible approach to cardiac gating at 7 T.
Shortened Modified Look-Locker Inversion recovery
(ShMOLLI) for clinical myocardial T1-mapping at 1.5 and
3 T within a 9 heartbeat breathhold
This manuscript is of interest to the CMR community,
since many advanced CMR sites are currently moving to
quantitative techniques for the assessment of myocardial
injury [122]. The authors present a modified version of the
MOLLI T1 mapping technique. The proposed method
could offer help for some patients with breath-hold diffi-
culty as it requires shorter acquisition times than the origi-
nal technique (9 vs. 17 heart beats). The approaches are
compared in simulations, phantoms, and 10 healthy volun-
teers at 1.5 T and 3 T. Finally, feasibility is also demon-
strated in 4 patients with acute myocardial infarction.
Cardiovascular magnetic resonance physics for clinicians:
part I
This is an excellent introduction into the basic physics
relating to cardiovascular magnetic resonance [123]. It
reviews the MR principles underlying T1 and T2 relaxa-
tion and net magnetization, describes the components of
the scanner (Main field, gradients, rf coils), describes
image acquisition (slice select, frequency encoding, phase
encoding), pulse sequences (GRE, SE, TSE), as well as
issues related to cardiac implementation. The text is very
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methodical way in which it is explained. Even the more
difficult concepts described later in the paper are
described very well and are easy to follow. Unlike many
physics texts that can be dominated by too much basic
physics that are not relevant to a basic understanding of
how the system works, even the more difficult concepts
are explained with reasoning behind their use and practi-
cal examples which help the explanation.
Varia
For busy practitioners of CMR, there is a well recognised
source of referrals which is simply put as unusual pathol-
ogy, or cases where other imaging has failed to yield a
definitive diagnosis, or where a research technique might
have clinical application. These include pericardial dis-
ease, [124,125] tumours, [126] or inflammatory diseases,
[127] amongst others. We therefore include this section
on papers and also include official reports, guidelines and
editorials, [128-131] which are not readily categorized.
Oxygenation-sensitive CMR for assessing vasodilator-
induced changes of myocardial oxygenation
As myocardial oxygenation may serve as a marker for
ischemia and microvascular dysfunction, it could be clini-
cally useful to have a non-invasive measure of changes in
myocardial oxygenation, however the impact of induced
blood flow changes on oxygenation is not well understood.
Vohringer et al used oxygenation-sensitive CMR to assess
the relation between myocardial oxygenation, coronary
sinus blood oxygen saturation (SvO2) and coronary blood
flow in a dog model in which hyperemia was induced by
intracoronary administration of vasodilators [132]. During
acetylcholine and adenosine injection, CMR signal inten-
sity correlated linearly with simultaneously measured
SvO2 (r2 = 0.74, P < 0.001). Both SvO2 and CMR signal
intensity were exponentially related to coronary blood
flow, with SvO2 approaching 87%. The authors concluded
that oxygenation-sensitive CMR may be useful to assess
ischemia and microvascular function in patients and that
its clinical utility should be evaluated.
Quantification of global myocardial oxygenation in
humans: initial experience
McCommis et al assessed the feasibility of new CMR
methods to quantify global and/or regional myocardial
oxygen consumption rate (MVO2) at rest and during
pharmacologically induced vasodilation in 6 normal volun-
teers [133]. A breath-hold T2 quantification method was
developed to calculate) and MVO2 rate at rest and/or dur-
ing hyperemia, using a two-compartment model. A pre-
viously reported T2 quantification method using turbo-
spin-echo sequence was also applied for comparison. The
T2 quantification method yielded a hypaeremic OEF of
0.37 ± 0.05 and a hyperaemic MVO2 of 9.2 ± 2.4 μmol/g/
min. The corresponding resting values were 0.73 ± 0.05
and 5.2 ± 1.7 μmol/g/min respectively, which agreed well
with published literature values. The MVO2 rose propor-
tionally with rate-pressure product from the rest condi-
tion. The T2 sensitivity was approximately 95% higher
with the new T2 method than turbo-spin-echo method.
The authors conclude that the CMR has potential for
non-invasive estimation of myocardial oxygenation.
Quantitative cardiovascular magnetic resonance for
molecular imaging
Winter et al review the growing field of CMR molecular
imaging, which aims to identify and map the expression
of important biomarkers on a cellular scale utilizing con-
trast agents that are specifically targeted to the biochem-
ical signatures of disease and are capable of generating
sufficient image contrast [134]. Examples are presented
that utilize a number of different molecular imaging
quantification techniques, including measuring signal
changes, calculating the area of contrast enhancement,
mapping relaxation time changes or direct detection of
contrast agents through multi-nuclear imaging or spec-
troscopy. The clinical application of CMR molecular ima-
ging could offer far reaching benefits to patient
populations, including early detection of therapeutic
response, localizing ruptured atherosclerotic plaques,
stratifying patients based on biochemical disease markers,
tissue-specific drug delivery, confirmation and quantifica-
tion of end-organ drug uptake, and non-invasive moni-
toring of disease recurrence. Eventually, such agents may
play a leading role in reducing the human burden of car-
diovascular disease, by providing early diagnosis, non-
invasive monitoring and effective therapy with reduced
side effects.
Cardiovascular magnetic resonance and PET-CT of left
atrial paraganglioma
Tomasian et al report a beautifully illustrated case of left
atrial paraganglioma with striking PET-CT and CMR
images [135].
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